Zachariah McIver
CIK: 0002050056
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JANX
Janux Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About McIver Zachariah
McIver Zachariah (SEC CIK 0002050056) files insider reports with the SEC as Chief Medical Officer of Janux Therapeutics, Inc. (JANX).
Signal8 holds 3 ownership filings by McIver Zachariah (1 Form 3, 2 Form 4), filed between Jan 3, 2025 and Jan 2, 2026. Those filings report 3 transactions, from Jan 2, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on McIver Zachariah's filings is in SAN DIEGO, CA.
Recent filings by McIver Zachariah
Other insiders filing for Janux Therapeutics, Inc. (JANX)
- Campbell David Alan, President and CEO
- RA CAPITAL MANAGEMENT, L.P., Director
- Simson Jake, Director
- Kung Winston, Director
- Hernday Natasha, Director
- DOBMEIER ERIC, Director